M&As this week: UnitedHealth, Stada Arzneimittel, Fresenius


UnitedHealth Group has reached an agreement to acquire 80% stake in healthcare services provider American Health Network in order to expand its business.

Both companies involved in the transaction are based in the US.

The target company will become a part of the acquirer company’s OptumCare division, following the completion of the transaction.

Private equity (PE) firms Bain Capital Private Equity and Cinven Partners have reached an agreement over a takeover offer to acquire the entire outstanding shares of German-based pharmaceutical and healthcare company Stada Arzneimittel for approximately €4.1bn ($4.34bn).

"German healthcare company Fresenius SE & Co. has announced its plans to acquire Akorn, which has a current market value of approximately $3.7bn."

The offer price represents an enterprise value of €5.3bn ($5.61bn).

The PE firms have agreed to pay €66 ($69.87) a share, which includes 2016 dividend of €0.72 ($0.76) a share proposed by Stada Arzneimittel’s management board, to the target company’s shareholders.

German healthcare company Fresenius SE & Co. has announced its plans to acquire US-based pharmaceutical company Akorn, which has a current market value of approximately $3.7bn.

The acquisition is expected to complement the acquirer company’s Kabi medicines division.